Navigation Links
Pharma Wholesale and Distribution Market: World Outlook 2012-2022
Date:8/2/2012

and Distributors in 2012

5.1 Revenue vs. Profit

5.1.1 Profit Margins

5.2 Leading Companies: Grouped Forecasts, 2012-2022

5.3 McKesson

5.3.1 Recent Performance

5.3.2 Future Strategies

5.3.3 Revenue Forecast, 2012-2022

5.4 Cardinal Health

5.4.1 Segment Reorganisation

5.4.2 Recent Performance

5.4.3 Future Strategies

5.4.4 Revenue Forecast, 2012-2022

5.5 AmerisourceBergen

5.5.1 Recent Performance

5.5.2 Future Strategies

5.5.3 Revenue Forecast, 2012-2022

5.6 The PHOENIX Group

5.6.1 Recent Performance

5.6.2 The Tamro Group 2011

5.6.3 Future Strategies

5.6.4 Revenue Forecast, 2012-2022

5.7 Alfresa Holdings

5.7.1 Recent Performance

5.7.2 Future Strategies

5.7.3 Revenue Forecast, 2012-2022

5.8 Celesio

5.8.1 Recent Performance

5.8.2 Future Strategies

5.8.3 Revenue Forecast, 2012-2022

5.9 Alliance Boots

5.9.1 Recent Performance

5.9.2 Future Strategies

5.9.3 Revenue Forecast, 2012-2022

5.10 Suzuken

5.10.1 Recent Performance

5.10.2 Future Strategies

5.10.3 Revenue Forecast, 2012-2022

5.11 Medipal

5.11.1 Recent Performance

5.11.2 Future Strategies

5.11.3 Revenue Forecast, 2012-2022

6. Qualitative Industry and Market Analyses, 2012-20226.1 Strengths6.1.1 Large Companies Dominate the Market6.1.2 Wholesalers Do More than Deliver Drugs6.1.2.1 Pre-Wholesaling6.2 Weaknesses6.2.1 Counterfeiting6.2.2 Low Margins6.3 Opportunities6.3.1 Increased Demand for Pharmaceuticals6.3.2 Generics6.3.3 Globalisation6.4 Threats6.4.1 Direct-to-Pharmacy (DTP)6.4.1.1 DTP in Europe6.4.1.2 The UK6.4.1.3 Poland6.4.1.4 DTP in Australia6.4.1.5 Further Expansion6.4.2 Healthcare Budget Cuts6.4.3 Diversion and Re-importation6.4.4 Supermarket Pharmacies6.4.4.1 Case Study: Walmart

7. Pharmaceutical Wholesale Indust
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
2. Onyx Pharmaceuticals Reports Second Quarter 2012 Financial Results
3. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
4. Genelex Receives First Patent on Business Methods for Pharmacogenetics
5. Qforma Chief Technologist Honored as One of PharmaVOICE Magazines "100 Most Inspiring People in the Life Sciences"
6. MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
7. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
8. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
9. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
10. CPhI China 2012 Breaks Attendance Records in Growing Pharma Market
11. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... -- Amgen (NASDAQ: AMGN ) will present at ... Thursday, May 30, 2013, at the Westin Boston Waterfront Hotel, ... Daylight Time. Arvind Sood , vice president ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... ULURU Inc. (NYSE AMEX: ... development of a portfolio of wound management and oral ... for investment commitments with Ironridge Global BioPharma and its ... transactions, subject to certain conditions, to purchase common and ...
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
Cached Medicine Technology:ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 2ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6
(Date:5/25/2013)... Dr. Leslie Gerstman announced today that ... skin on the neck, on the brow and under the ... , Ultherapy is a non-surgical procedure for the face and ... lift the skin over time. The use of FDA-cleared ultrasound ... then treat the deepest support layers of the skin – ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Actos ... underway in U.S. District Court, Western District of Louisiana, ... According to a Case Management Order issued on May ... filing of contested motions in the Actos bladder cancer ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
(Date:5/25/2013)... Studies from Johns Hopkins University reveal a ... and their inability to get adequate sleep. These same ... naturally relieve many symptoms. , Johns Hopkins University ... was significantly associated with overall weight loss, especially belly ... November 6th, 2012, researchers monitored 77 participants who were ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...
(Date:5/25/2013)... 2013 Dr. Farooq Ashraf, founder of ... Dubai, has announced his practice’s adoption of The iFS ... FDA-cleared femtosecond laser proven with more than 10 years ... of LASIK. , “We are happy to announce that ... at our Dubai LASIK practice,” Ashraf said Thursday. “We ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2
... Oyster-related infections up, while Salmonella plateaus, says CDC report ... report a continuing decline in food-related illnesses caused by several ... , But Vibrio , a pathogen most often acquired ... is on the rise, while rates of Salmonella infection have ...
... says back disorders in the working population are among ... world. Disc degeneration is the main suspected origin of ... surgery. But Videman, a researcher in the University of ... common perception that disc degeneration is caused by physical ...
... Low levels of vitamin D are associated with lower lung ... to researchers at National Jewish Health. In a paper published ... Clinical Immunology, Daniel Searing, MD, and his colleagues also ... most effective controller medication for asthma. , "Asthmatic children in ...
... ... that Maureen Hanrahan has joined the company as a senior consultant specializing in managed ... SCHIP. , ... April 15, 2010 -- ArpegioHealth is pleased to announce that Maureen Hanrahan ...
... ... Workers’ Compensation claim for the amount of $34,000.00. , ... New Bedford, MA (PRWEB) April, 15, 2010 -- The law firm of Dussault and ... , ,The employee was injured while on the job while working as a truck-cleaner. The ...
... management of related condition leaves many undiagnosed, , THURSDAY, ... often fail to detect cases of chlamydia in young ... researchers contend. , They say that many urologists are ... known as epididymo-orchitis, which causes inflammation of the testicle ...
Cached Medicine News:Health News: E. coli Declines, but Other Foodborne Illnesses a Worry 2Health News: E. coli Declines, but Other Foodborne Illnesses a Worry 3Health News:Low vitamin D levels associated with more asthma symptoms and medication use 2Health News:Hanrahan Joins ArpegioHealth Consulting Firm 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: